Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Tags
NASDAQ:ACRS
Tag: NASDAQ:ACRS
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Files An 8-K Costs Associated with Exit...
ME Staff 8-k
-
September 5, 2019
0
Aclaris Therapeutics Inc (NASDAQ:ACRS) had its Overweight rating reiterated by Cantor...
ME Staff
-
August 9, 2019
0
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Files An 8-K Departure of Directors or...
ME Staff 8-k
-
July 4, 2019
0
Aclaris Therapeutics Inc (NASDAQ:ACRS) gets downgraded to Market Perform by Svb...
ME Staff
-
June 27, 2019
0
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Files An 8-K Regulation FD Disclosure
ME Staff 8-k
-
June 17, 2019
0
Aclaris Therapeutics Inc (NASDAQ:ACRS) price target lowered to $24.00 by Cantor...
ME Staff
-
June 12, 2019
0
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Files An 8-K Departure of Directors or...
ME Staff 8-k
-
June 7, 2019
0
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Files An 8-K Regulation FD Disclosure
ME Staff 8-k
-
June 5, 2019
0
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Files An 8-K Regulation FD Disclosure
ME Staff 8-k
-
April 4, 2019
0
Aclaris Therapeutics Inc (NASDAQ:ACRS) had its Buy rating reiterated by Cantor...
ME Staff
-
March 22, 2019
0
1
2
3
...
6
Page 2 of 6
